Dissemination of the European Association of Urology Guidelines Through Social Media: Strategy, Results, and Future Developments.

Clinical practice guidelines Dissemination Education European association of urology Social media Twitter Urology

Journal

European urology focus
ISSN: 2405-4569
Titre abrégé: Eur Urol Focus
Pays: Netherlands
ID NLM: 101665661

Informations de publication

Date de publication:
09 2022
Historique:
received: 10 08 2021
revised: 08 10 2021
accepted: 20 10 2021
pubmed: 15 11 2021
medline: 6 12 2022
entrez: 14 11 2021
Statut: ppublish

Résumé

Over the past decade, social media (SoMe) platforms have been embraced by the medical community across all specialties. This engagement creates a valuable opportunity for scientific organizations to use the broad reach, accessibility, functionality, and informal environment of SoMe to raise awareness, reinforce trust with stakeholders, and disseminate scientific information. In this field, the European Association of Urology (EAU) Guidelines Office has been a pioneer and has constantly set out to disseminate the recommendations established annually by its guidelines panels. Here we describe the dissemination strategy used by the EAU Guidelines Office and the results obtained in the past few years. The EAU Guidelines Office proposes various types of content to disseminate on the different SoMe platforms. An ad hoc dissemination committee adapts attractive content for different target audiences to fit the specific requirements of the platforms on which it is published. Over the past 5 yr, the dissemination committee has been able to constantly improve the engagement of different audiences, especially using Twitter, Facebook, and, more recently, Instagram. It has been shown that use of a multifaceted strategy to improve dissemination of the guidelines, such as campaigns for awareness days, is successful. PATIENT SUMMARY: We describe the strategy used by the European Association of Urology Guidelines Office to disseminate recommendations from the association's guidelines to different target audiences via social media and we summarize the main results.

Identifiants

pubmed: 34774465
pii: S2405-4569(21)00289-3
doi: 10.1016/j.euf.2021.10.010
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1541-1544

Informations de copyright

Copyright © 2021 European Association of Urology. Published by Elsevier B.V. All rights reserved.

Auteurs

Benjamin Pradere (B)

Department of Urology, Comprehensive Cancer Centre, Medical University of Vienna, Vienna, Austria. Electronic address: benjaminpradere@gmail.com.

Francesco Esperto (F)

Department of Urology, Campus Bio-Medico University, Rome, Italy.

Inge M van Oort (IM)

Department of Urology, Radboud University Medical Centre, Nijmegen, The Netherlands.

Nikita R Bhatt (NR)

Department of Urology, East of England Deanery, Cambridge, UK.

Stefan W Czarniecki (SW)

HIFU CLINIC Prostate Cancer Centre, Warsaw, Poland.

Marc van Gurp (M)

Communications Section, European Association of Urology, Arnhem, The Netherlands.

Jarka Bloemberg (J)

Communications Section, European Association of Urology, Arnhem, The Netherlands.

Julie Darraugh (J)

Guidelines Office, European Association of Urology, Arnhem, The Netherlands.

Esther Garcia-Rojo (E)

Department of Urology, Hospital HM Sanchinarro, Madrid, Spain.

Vito Cucchiara (V)

Department of Urology, Division of Experimental Oncology, Urological Research Institute, Vita-Salute San Raffaele University, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Jeremy Y Teoh (JY)

S.H. Ho Urology Centre, Department of Surgery, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, China.

James N'Dow (J)

Department of Urology, Aberdeen Royal Infirmary, NHS Grampian, Aberdeen, UK.

Gianluca Giannarini (G)

Urology Unit, Santa Maria della Misericordia University Hospital, Udine, Italy.

Maria J Ribal (MJ)

Uro-Oncology Unit, Hospital Clinic, University of Barcelona, Barcelona, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH